Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Fianlimab

   Regeneron UK Limited

   Melanoma

   phase 3 · small molecule · active

   3 trials →

2. Ficerafusp alfa

   Bicara Therapeutics

   Metastatic Head and Neck Squamous Cell Carcinoma

   phase 3 · small molecule · active

   1 trial →

3. Firmonertinib

   ArriVent BioPharma

   Non-Small-Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

4. Fluzoparib

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Breast Cancer Metastatic

   phase 3 · small molecule · active

   2 trials →

5. ForeCYTE Breast Aspirator

   ATOSSA THERAPEUTICS, INC.

   Breast Cancer, Preneoplastic Conditions, BRCA

   phase 3 · other · terminated

   1 trial →

6. Fulvestrant

   Novartis Pharmaceuticals

   Metastatic Breast Cancer

   phase 3 · small molecule · terminated

   1 trial →

7. Fulvestrant

   Novartis Pharmaceuticals

   Breast Cancer

   phase 3 · small molecule · completed

   1 trial →

8. Fulvestrant combined with Pyrotinib

   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

   Breast Cancer

   phase 3 · small molecule · active

   1 trial →

9. Futibatinib, FULVESTRANT

   Taiho Pharma Netherlands B.V.

   Malignant Solid Tumors

   phase 3 · small molecule · active

   1 trial →

10. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Carcinoma of the parotid gland

    phase 3 · small molecule · active

    1 trial →

11. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Endometrial cancer, uterine cancer

    phase 3 · small molecule · active

    1 trial →

12. GCAR-7213

    Adaptive Biotechnologies Corp

    Oncology - Glioblastoma (GBM)

    phase 3 · small molecule · active

    1 trial →

13. GCO-003 TARLANEC

    CERO THERAPEUTICS HOLDINGS, INC.

    Advanced pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine carcinomas (NECs)

    phase 3 · small molecule · active

    1 trial →

14. GCT1046-06

    Genmab A/S

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

15. GCT1184-02

    Genmab A/S

    Platinum-resistant Ovarian Cancer

    phase 3 · small molecule · active

    1 trial →

16. GCT1184-03

    Genmab A/S

    Endometrial Cancer Advanced, Recurrent, Metastatic, or Primary Unresectable Endometrial Cancer

    phase 3 · small molecule · active

    1 trial →

17. GCT3013-05

    Genmab A/S

    B-cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

18. GEICAM/2011-03_S1007

    Ningbo Cancer Hospital

    patients with node positive breast cancer who do not have high Recurrence Scores (RS) by Oncotype DX®

    phase 3 · small molecule · active

    1 trial →

19. GEMCITABINE for Patients with histologically or…

    AstraZeneca AB

    Patients with histologically or cytologically documented muscle-invasive transitional cell carcinoma (TCC) of the bladder

    phase 3 · small molecule · active

    1 trial →

20. GIMEMA AML1919

    Fondazione Telethon ETS

    Acute Myeloid Leukemia (LMA) with FLT3 mutation

    phase 3 · small molecule · active

    1 trial →

21. GLUCOPHAGE 500 mg tabletki powlekane, Placebo

    Bial Portela & Companhia S.A.

    papillary thyroid carcinoma

    phase 3 · small molecule · active

    1 trial →

22. GO29431

    Hoffmann-La Roche

    Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

23. GO29527

    Hoffmann-La Roche

    Non−Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

24. GO39942

    Hoffmann-La Roche

    Previously Untreated Diffuse large B-cell lymphoma (DLBCL)

    phase 3 · small molecule · active

    1 trial →

25. GO40241

    Hoffmann-La Roche

    Early-Stage Resectable Non-small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

26. GO41717

    Hoffmann-La Roche

    Non-small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

27. GO41767

    Hoffmann-La Roche

    Small cell lung cancer (SCLC)

    phase 3 · small molecule · active

    1 trial →

28. GO41854

    Hoffmann-La Roche

    Non−small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

29. GO41944

    Hoffmann-La Roche

    Relapsed or refractory diffuse large B-cell lymphoma

    phase 3 · small molecule · active

    1 trial →

30. GO42909

    Hoffmann-La Roche

    Relapsed/refractory follicular lymphoma

    phase 3 · other · active

    1 trial →

31. GO43104

    Hoffmann-La Roche

    Small-Cell Lung Cancer (SCLC)

    phase 3 · small molecule · active

    1 trial →

32. GO45006

    Hoffmann-La Roche

    Non-Small Cell Lung Cancer

    phase 3 · other · active

    1 trial →

33. GS-US-577-6153

    Gilead Sciences Pty Limited

    Non-small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

34. GS-US-592-6173

    Gilead Sciences Pty Limited

    PD-L1 Positive Metastatic Triple-Negative Breast Cancer

    phase 3 · small molecule · active

    1 trial →

35. GS-US-592-6238

    Gilead Sciences Pty Limited

    PD-L1-negative metastatic triple-negative breast cancer or PD-L1-positive metastatic triple-negative breast cancer previously treated with an anti-PD-(L)1 agent in the curative setting

    phase 3 · small molecule · active

    1 trial →

36. GS-US-595-6184

    Gilead Sciences Pty Limited

    Triple Negative Breast Cancer

    phase 3 · small molecule · active

    1 trial →

37. GS-US-600-6165

    Gilead Sciences Pty Limited

    Extensive Stage Small Cell Lung Cancer (ES-SCLC)

    phase 3 · small molecule · active

    1 trial →

38. GS-US-626-6216

    Gilead Sciences Pty Limited

    Metastatic Non–Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

39. GS-US-682-6769

    Gilead Sciences Pty Limited

    Recurrent or Persistent Endometrial Cancer

    phase 3 · small molecule · active

    1 trial →

40. GSK 2132231A

    GlaxoSmithKline

    Melanoma

    phase 3 · small molecule · terminated

    1 trial →

41. GSK2118436

    GlaxoSmithKline

    Cancer

    phase 3 · small molecule · completed

    1 trial →

42. Ga-68-PSMA-11

    Telix Innovations

    Prostate Cancer

    phase 3 · small molecule · terminated

    1 trial →

43. Gefitinib

    AstraZeneca

    Non-Small-Cell Lung Carcinoma

    phase 3 · small molecule · completed

    1 trial →

44. Gefitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

45. Gemcitabine

    AstraZeneca

    Biliary Tract Cancer

    phase 3 · small molecule · active

    1 trial →

46. Gemcitabine,Cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 · small molecule · active

    1 trial →

47. General anesthesia and opioids

    Elan Pharma International

    Breast Neoplasms

    phase 3 · small molecule · completed

    1 trial →

48. Gilteritinib

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia (AML)

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions